Dr. Bijal Shah is an oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from University of South Florida Morsani College of Medicine and has been in practice 13 years. He is one of 172 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Oncology. He has more than 100 publications and over 500 citings.
Jenny M H Chen, Ina Zhang, Fabio Kerbauy, James J Wu, Sally W Wade, Ana Nunes, Chaoling Feng, Ioana Kloos, Weimin Peng, Julia T Snider, Dylan Maciel, Keith Chan, Sam K...> ;Advances in Therapy. 2024 May 1
Dean, E., Rawan G Faramand, Sae Bom Lee, Michael D Jain, Biwei Cao, Xuefeng Wang, Kai Rejeski, Marion Subklewe, Johannes F Fahrmann, Neeraj Y Saini, Samir M Hanash, Yu...> ;Blood Cancer Discovery. 2024 Mar 1
Julio C Chavez, Ariel Grajales, Jose Sandoval-Sus, Elyce Turba, Lisa Nodzon, Angimar Uriepero-Palma, Mohammad Ammad-Ud-Din, Eva Sahakian, Rami Komrokji, Lubomir Sokol,...> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Feb 13
Patel, A. A., Caner Saygin, Pu Zhang, Jacob Stauber, Ibrahim Aldoss, Adam S Sperling, Lachelle D Weeks, Marlise R Luskin, Todd C Knepper, Pankhuri Wanjari, Peng Wang, ...> ;Blood Cancer Discovery. 2023 Dec 27
Gerson, J., Handorf, E., Villa, D., Gerrie, A., Chapani, P., Li, S., Medeiros, L., Wang, M., Cohen, J., Churnetski, M., Hill, B., Sawalha, Y., Hernandez-Ilizaliturri, ...> ;Blood Advances. 2023 Dec 26
Aref Al-Kali, Ibrahim Aldoss, Pamela J Atherton, Carrie A Strand, Bijal Shah, Jonathan Webster, Bhavana Bhatnagar, Karen S Flatten, Kevin L Peterson, Paula A Schneider...> ;Cancer Medicine. 2023 Dec 1
Bijal Shah, Jenny M H Chen, James J Wu, Chaoling Feng, Lang Zhou, Julie E Park, Tsveta Hadjiivassileva, Fabio R Kerbauy, Sally W Wade, Sam Keeping> ;Advances in Therapy. 2023 Dec 1
Samuel Yamshon, Gui Zhen Chen, Caitlin Gribbin, Paul Christos, Bijal Shah, Stephen J Schuster, Sonali M Smith, Jakub Svoboda, Richard R Furman, John P Leonard, Peter M...> ;Blood Advances. 2023 Nov 14
Kai Rejeski, Yucai Wang, Omar Albanyan, Javier Munoz, Pierre Sesques, Gloria Iacoboni, Lucia Lopez-Corral, Isabelle Ries, Veit L Bücklein, Razan Mohty, Martin Dreyling...> ;American Journal of Hematology. 2023 Nov 1
Bijal D Shah, Ryan D Cassaday, Jae H Park, Roch Houot, Olalekan O Oluwole, Aaron C Logan, Nicolas Boissel, Thibaut Leguay, Michael R Bishop, Max S Topp, Dimitrios Tzac...> ;Journal for Immunotherapy of Cancer. 2023 Aug 1
Franco Locatelli, Bijal Shah, Tracy Thomas, Kelly Velasco, Babatunde Adedokun, Ibrahim Aldoss, Lia Gore, Dieter Hoelzer, Renato Bassan, Jae H Park, Nicolas Boissel, Ha...> ;Leukemia & Lymphoma. 2023 Oct 1
Steven Le Gouill, Monika Długosz-Danecka, Simon Rule, Pier Luigi Zinzani, Andre Goy, Stephen D Smith, Jeanette K Doorduijn, Carlos Panizo, Bijal D Shah, Andrew J Davie...> ;Haematologica. 2024 Jan 1
Jeremy S Abramson, Elizabeth Bengston, Robert Redd, Jeffrey A Barnes, Tak Takvorian, Lubomir Sokol, Frederick Lansigan, Philippe Armand, Bijal Shah, Eric Jacobsen, Ros...> ;Blood Advances. 2023 Apr 11
Ning Dong, Lucía Rubio Lopes-Garcia, David Viñal, Christina Bachmeier, Bijal D Shah, Taiga Nishihori, Farhad Khimani, Marco L Davila, Aleksandr Lazaryan, Javier Pinill...> ;Transplantation and Cellular Therapy. 2023 Jun 1
Yucai Wang, Preetesh Jain, Frederick L Locke, Matthew J Maurer, Matthew J Frank, Javier L Munoz, Saurabh Dahiya, Amer M Beitinjaneh, Miriam T Jacobs, Joseph P Mcguirk,...> ;Journal of Clinical Oncology. 2023 May 10
Ibrahim Aldoss, Bijal D Shah, Jae H Park, Lori Muffly, Aaron C Logan, Patrick Brown, Wendy Stock, Elias J Jabbour> ;American Journal of Hematology. 2023 Apr 1
Matthew Frigault, Anand Rotte, Ayub Ansari, Bradford Gliner, Christopher Heery, Bijal Shah> ;Journal of Experimental & Clinical Cancer Research. 2023 Jan 10
Yumeng Zhang, Lynn Nguyen, Chuanyi M Lu, Endi Wang, Marietya I S Lauw, Somedeb Ball, Ning Dong, Lynn Moscinski, Onyee Chan, Seongseok Yun, David Sallman, Lubomir Sokol...> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Mar 1
Bijal D Shah, Armin Ghobadi, Olalekan O Oluwole, Aaron C Logan, Nicolas Boissel, Ryan D Cassaday, Thibaut Leguay, Michael R Bishop, Max S Topp, Dimitrios Tzachanis, Kr...> ;Journal of Hematology & Oncology. 2022 Dec 10
AG-636 for the Treatment of Adults with Advanced Lymphoma: Initiation of a Phase 1 Clinical Study
Bijal Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Impact of TBI-Based Conditioning Regimen on Outcomes of Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplant: Systematic Revi...
Bijal Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Use of Lenalidomide Plus Rituximab in TP53-Mutated Mantle Cell Lymphoma (MCL) Outside of Clinic Trial: The Moffitt Experience
Bijal Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Initial Findings of the Phase 1 Trial of PBCAR0191, a CD19 Targeted Allogeneic CAR-T Cell Therapy
Bijal Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Impact of Interim FDG-PET (iPET) in the Outcomes of Patients with Aggressive B-Cell Lymphomas Receiving DA-EPOCH-R
Bijal Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Moffitt Cancer Center 2-Year Single-Institution Experience with Next-Generation Sequencing Minimal Residual Disease Detection: Clinical Utility, Application, and Corre...
Bijal Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Fever Characteristics Associated with Toxicity and Outcome after Anti-CD19 CAR T-Cell Therapy for Aggressive Lymphoma
Bijal Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
The Lymphoma Tumor Microenvironment Influences Toxicity after CD19 CAR T Cell Therapy
Bijal Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
End of phase I results of ZUMA-3, a phase 1/2 study of KTE-X19, anti-CD19 chimeric antigen receptor (CAR) T cell therapy, in adult patients (pts) with relapsed/refract...
2019 ASCO Annual Meeting - 6/1/2019
A Phase II Study of Brentuximab Vedotin Plus Adriamycin and Dacarbazine without Radiation in Non-Bulky Limited Stage Classical Hodgkin Lymphoma
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Outcomes of patients (pts) treated with prior blinatumomab (Blin) in ZUMA-3: A study of KTE-C19, an anti-CD19 chimeric antigen receptor (CAR) t cell therapy, in adult ...
Tecartus® Car T-cell Therapy Demonstrates Strong Overall Survival Rates and Continued Durable Responses in Long-Term Follow-up of Two Pivotal Studies Including Longest Ever Follow-up of a CAR T-cell Therapy in Mantle Cell LymphomaJune 4th, 2022
Kite’s Tecartus Is First CAR T Therapy Approved for Adults with B-cell ALLOctober 4th, 2021
U.S. FDA Approves Kite’s Tecartus® as the First and Only Car T for Adults with Relapsed or Refractory B-cell Acute Lymphoblastic LeukemiaOctober 2nd, 2021